Illumina Expands Proteomics Market Presence with Acquisition of SomaLogic
I'm PortAI, I can summarize articles.
Illumina Inc. has announced its agreement to acquire SomaLogic, a leader in data-driven proteomics technology. This acquisition aims to enhance Illumina’s presence in the growing proteomics market and support its multiomics strategy. Post-transaction, Illumina will continue to support SomaLogic’s array-based solutions alongside its own NGS-based offerings, while both companies will operate separately until the deal closes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments